Yuvraj_pawp, Author at Pharma Advancement

AstraZeneca is proud to support a new Insight by Nature on precision medicine. Currently, 80% of our pipeline takes a...

AstraZeneca receives Complete Response Letter from US FDA for saxagliptin / dapagliflozin fixed-dose-combination

by Yuvraj_pawp

24th October 2015

AstraZeneca today announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the...

AstraZeneca opens new manufacturing facility to support continued growth in Russia

by Yuvraj_pawp

24th October 2015

AstraZeneca today announced the opening of its new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local...

AstraZeneca and Lilly expand immuno-oncology research collaboration with new combinations

by Yuvraj_pawp

24th October 2015

AstraZeneca and Eli Lilly and Company (Lilly) today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies...

FDA Advisory Committee recommends the approval of lesinurad for gout patients

by Yuvraj_pawp

24th October 2015

AstraZeneca today announced that the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10 to 4 to...

Post-Merger with Ranbaxy, Sun Pharma Becomes 5th Largest Generic Company

by Yuvraj_pawp

24th October 2015

Following the successful closure of the merger with drug maker Ranbaxy, Dilip Shanghvi-led Sun Pharma said on Wednesday that it...

Sun Seals Ranbaxy Deal, To Invest $300 MN in R&D

by Yuvraj_pawp

24th October 2015

Sun Pharmaceutical Industries, India’s largest drugmaker, on Wednesday announced the closure of its merger with Ranbaxy Laboratories and said the...

We would like to make one plus one more than two: Uday Baldota

by Yuvraj_pawp

24th October 2015

Sun Pharmaceutical Industries is in the process of closing its merger with Ranbaxy. The former's chief financial officer (CFO), Uday...

Sun Pharmaceutical wins US approval to buy Ranbaxy

by Yuvraj_pawp

24th October 2015

Sun Pharmaceutical Industries LtdBSE -0.35 % has won US approval to buy Ranbaxy Laboratories LtdBSE -0.61 % on condition that...

Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive Forms of Multiple Sclerosis

by Yuvraj_pawp

24th October 2015

Genentech, a member of the Roche group announced data from three positive, pivotal Phase III studies of ocrelizumab in people...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Yuvraj_pawp

AstraZeneca is proud to support a new Insight by Nature on precision medicine

AstraZeneca receives Complete Response Letter from US FDA for saxagliptin / dapagliflozin fixed-dose-combination

AstraZeneca opens new manufacturing facility to support continued growth in Russia

AstraZeneca and Lilly expand immuno-oncology research collaboration with new combinations

FDA Advisory Committee recommends the approval of lesinurad for gout patients

Post-Merger with Ranbaxy, Sun Pharma Becomes 5th Largest Generic Company

Sun Seals Ranbaxy Deal, To Invest $300 MN in R&D

We would like to make one plus one more than two: Uday Baldota

Sun Pharmaceutical wins US approval to buy Ranbaxy

Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive Forms of Multiple Sclerosis

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password